References
- Wood DM, Davies S, Greene SL, et al. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol. 2010;48:924–927.
- Umebachi R, Aoki H, Sugita M, et al. Clinical characteristics of α-pyrrolidinovalerophenone (α-PVP) poisoning. Clin Toxicol. 2016;54:563–567.
- Beck O, Franzén L, Bäckberg M, et al. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol. 2016;54:568–575.
- Patel N, Ford L, Jones R, et al. Poisoning to α-pyrrolidinovalerophenone (α-PVP), a synthetic cathinone [letter]. Clin Toxicol. Forthcoming. [2 p.]. DOI:10.1080/15563650.2016.1248291.
- Hamby D, Burnett A, Jablonsky M, et al. Identification of 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone (4-MEAP), a new “legal high” sold by an internet vendor as 4-methyl pentedrone. J Forensic Sci. 2015;60:721–726.
- Ford LT, Berg JD. Analysis of legal high materials by UPLC-MS/TOF as part of a toxicology vigilance system. What are the most popular novel psychoactive substances in the UK? Ann Clin Biochem. 2016;53:640–646.
- Martínez-Clemente J, Escubedo E, Pubill D, et al. Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol. 2012;22:231–236.
- Baumann MH, Ayestas MA Jr, Partilla JS, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2012;37:1192–1203.